000			01566 a2200421 4500
005			20250516190558.0
264		0	_c20141208
008			201412s 0 0 eng d
022			_a2051-5960
024	7		_a10.1186/2051-5960-2-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aKhan, Reas S
245	0	0	_aSIRT1 activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease. _h[electronic resource]
260			_bActa neuropathologica communications _cJan 2014
300			_a3 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnalysis of Variance
650	0	4	_aAnimals
650	0	4	_aCarbazoles _xtherapeutic use
650	0	4	_aDemyelinating Autoimmune Diseases, CNS _xdrug therapy
650	0	4	_aDisease Models, Animal
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aHepatitis Viruses _xpathogenicity
650	0	4	_aHepatitis, Viral, Animal _xcomplications
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aNeurons _xpathology
650	0	4	_aOxidative Stress _xdrug effects
650	0	4	_aSirtuin 1 _xantagonists & inhibitors
650	0	4	_aStilbamidines
650	0	4	_aTime Factors
700	1		_aDine, Kimberly
700	1		_aDas Sarma, Jayasri
700	1		_aShindler, Kenneth S
773	0		_tActa neuropathologica communications _gvol. 2 _gp. 3
856	4	0	_uhttps://doi.org/10.1186/2051-5960-2-3 _zAvailable from publisher's website
999			_c23410464 _d23410464